GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mesoblast Ltd (OTCPK:MEOBF) » Definitions » Shiller PE Ratio

Mesoblast (Mesoblast) Shiller PE Ratio : (As of May. 22, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Mesoblast Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Mesoblast Shiller PE Ratio Historical Data

The historical data trend for Mesoblast's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mesoblast Shiller PE Ratio Chart

Mesoblast Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.53 0.57

Mesoblast Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.42 0.57 - - -

Competitive Comparison of Mesoblast's Shiller PE Ratio

For the Biotechnology subindustry, Mesoblast's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mesoblast's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mesoblast's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Mesoblast's Shiller PE Ratio falls into.



Mesoblast Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Mesoblast's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Mesoblast's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0/126.3989*126.3989
=0.000

Current CPI (Dec. 2023) = 126.3989.

Mesoblast Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201306 0.000 95.473 0.000
201312 0.000 97.330 0.000
201406 -0.117 98.352 -0.150
201412 -0.082 99.002 -0.105
201503 -0.066 99.187 -0.084
201506 -0.087 99.838 -0.110
201509 -0.037 100.302 -0.047
201512 -0.059 100.673 -0.074
201603 -0.042 100.488 -0.053
201606 0.128 100.859 0.160
201609 -0.050 101.602 -0.062
201612 -0.049 102.159 -0.061
201703 -0.023 102.624 -0.028
201706 -0.060 102.809 -0.074
201709 -0.015 103.460 -0.018
201712 0.028 104.110 0.034
201803 -0.042 104.574 -0.051
201806 -0.042 104.945 -0.051
201809 -0.039 105.410 -0.047
201812 -0.047 105.967 -0.056
201903 -0.047 105.967 -0.056
201906 -0.039 106.617 -0.046
201909 -0.010 107.174 -0.012
201912 -0.044 107.917 -0.052
202003 -0.027 108.289 -0.032
202006 -0.058 106.246 -0.069
202009 -0.040 107.917 -0.047
202012 -0.042 108.846 -0.049
202103 -0.042 109.496 -0.048
202106 -0.032 110.332 -0.037
202109 -0.033 111.168 -0.038
202112 -0.038 112.654 -0.043
202203 -3.110 115.069 -3.416
202206 10.088 117.112 10.888
202209 -0.023 119.248 -0.024
202212 -0.031 121.477 -0.032
202303 -2.399 123.148 -2.462
202306 7.755 124.170 7.894
202309 0.000 125.656 0.000
202312 0.000 126.399 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Mesoblast  (OTCPK:MEOBF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Mesoblast Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Mesoblast's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Mesoblast (Mesoblast) Business Description

Traded in Other Exchanges
Address
Level 38, 55 Collins Street, Melbourne, VIC, AUS, 3000
Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and for moderate to severe acute respiratory distress syndrome (ARDS) and others.